Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-049540
Filing Date
2016-02-01
Accepted
2016-02-01 16:32:48
Documents
1
Period of Report
2016-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6175
  Complete submission text file 0001140361-16-049540.txt   7609
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1204 MEADOWLARK DRIVE TOWSON MD 21286
Business Address
Suzdak Peter David (Reporting) CIK: 0001296629 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 161377693